Pine Pharmaceuticals, LLC recalls Bevacizumab 2.5 mg/0.1 mL, Solution for Injection in 1mL, silicone free slip tip syringe, each Syringe supplied in indi…

Recall date

March 27, 2023

Source

U.S. Food & Drug Administration (FDA) — enforcement report

Recall number

D-0531-2023

FDA classification

Class III

Brand / firm

Pine Pharmaceuticals, LLC

Sold / distributed

Nationwide in the USA

Why it was recalled

Labeling: Incorrect or Missing Lot and/or Exp Date: Lot code on primary packaging is incorrect.

Class III means the product violates regulations but is not likely to cause harm.

What was recalled

Bevacizumab 2.5 mg/0.1 mL, Solution for Injection in 1mL, silicone free slip tip syringe, each Syringe supplied in individually labeled poly envelopes (primary packaging). Repackaged by Pine Pharmaceuticals, Pine Pharmaceuticals 355 Riverwalk Parkway, Tonawanda, NY 14150, Office Use Only, Not for Resale. Secondary packaging consists of a coated cardboard box, with order-specific label indicating lot number housed within order/container. NDC # 69194-0458-1